Cardioprotection during cardiac surgery

Cardiovascular Research

Volumn 94, Issue 2, 2012, Pages 253-265

  Hausenloy, Derek J ^a   Boston Griffiths, Edney ^a   Yellon, Derek M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CABG surgery; Cardioprotection; Ischaemic postconditioning; Ischaemic preconditioning; Peri operative myocardial infarction; Peri operative myocardial injury; Remote ischaemic preconditioning

Indexed keywords

CARIPORIDE; CREATINE KINASE MB; DESFLURANE; DIAZOXIDE; ENFLURANE; ERYTHROPOIETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOFLURANE; PEXELIZUMAB; SEVOFLURANE; TROPONIN I; TROPONIN T;

AORTIC VALVE REPAIR; CARDIAC PATIENT; CORONARY ARTERY BYPASS GRAFT; FALLOT TETRALOGY; GENERAL ANESTHESIA; GENETIC PREDISPOSITION; HEART INFARCTION; HEART MUSCLE INJURY; HEART PROTECTION; HEART VENTRICLE CONTRACTION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MORBIDITY; MORTALITY; NONHUMAN; OFF PUMP CORONARY SURGERY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; HUMANS; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; REPERFUSION INJURY;

EID: 84860148712     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs131     Document Type: Review

References (137)

1. Ferguson TB Jr, Hammill BG, Peterson ED, DeLong ER, Grover FL. A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg 2002;73:480-489. (Pubitemid 34117395)
2. Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009;119:495-502.
3. Whitaker DC, Stygall J, Newman SP. Neuroprotection during cardiac surgery: strategies to reduce cognitive decline. Perfusion 2002;17(Suppl.):69- 75. (Pubitemid 34467141)
4. Cordell AR. Milestones in the development of cardioplegia. Ann Thorac Surg 1995;60: 793-796.
5. Nicolini F, Beghi C, Muscari C, Agostinelli A, Maria BA, Spaggiari I et al. Myocardial protection in adult cardiac surgery: current options and future challenges. Eur J Cardiothorac Surg 2003;24:986-993. (Pubitemid 37476376)
6. Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954;37:171-185.
7. Bigelow WG, Lindsay WK, Greenwood WF. Hypothermia; its possible role in cardiac surgery: an investigation of factors governing survival in dogs at low body temperatures. Ann Surg 1950;132:849-866.
8. Melrose DG, Dreyer B, Bentall HH, Baker JB. Elective cardiac arrest. Lancet 1955; 269:21-22.
9. Bretschneider HJ. Survival time and recuperative time of the heart in normothermia and hypothermia. Verh Dtsch Ges Kreislaufforsch 1964;30:11-34.
10. Hearse DJ, Stewart DA, Braimbridge MV. Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest. Circulation 1976;54:193-202.
11. Jynge P, Hearse DJ, Feuvray D, Mahalu W, Cankovic-Darracott S, O'Brien K et al. The St. Thomas' hospital cardioplegic solution: a characterization in two species. Scand J Thorac Cardiovasc Surg Suppl 1981;30:1-28.
12. Follette DM, Fey KH, Steed DL, Foglia RP, Buckberg GD. Reducing reperfusion injury with hypocalcemic, hyperkalemic, alkalotic blood during reoxygenation. Surg Forum 1978;29:284-286. (Pubitemid 10111397)
13. Okamoto F, Allen BS, Buckberg GD, Bugyi H, Leaf J. Reperfusion conditions: importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion. J Thorac Cardiovasc Surg 1986;92:613-620. (Pubitemid 16020177)
14. Heusch G. Postconditioning: old wine in a new bottle? J Am Coll Cardiol 2004;44: 1111-1112. (Pubitemid 39165148)
15. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-H588. (Pubitemid 36885888)
16. Karthik S, Grayson AD, Oo AY, Fabri BM. A survey of current myocardial protection practices during coronary artery bypass grafting. Ann R Coll Surg Engl 2004;86: 413-415. (Pubitemid 39462267)
17. Teoh KH, Christakis GT, Weisel RD, Fremes SE, Mickle DA, Romaschin AD et al. Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg 1986;91:888-895. (Pubitemid 16092991)
18. Akins CW. Noncardioplegic myocardial preservation for coronary revascularization. J Thorac Cardiovasc Surg 1984;88:174-181. (Pubitemid 14059431)
19. Bainbridge D, Martin J, Cheng D. Off pump coronary artery bypass graft surgery versus conventional coronary artery bypass graft surgery: a systematic review of the literature. Semin Cardiothorac Vasc Anesth 2005;9:105-111. (Pubitemid 40328240)
20. Heusch G. Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents. Br J Pharmacol 2008;153: 1589-1601. (Pubitemid 351535988)
21. Thielmann M, Massoudy P, Schmermund A, Neuhauser M, Marggraf G, Kamler M et al. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery. Eur Heart J 2005;26:2440-2447. (Pubitemid 41552974)
22. Heusch G, Kleinbongard P, Bose D, Levkau B, Haude M, Schulz R et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation 2009; 120:1822-1836.
23. Kleinbongard P, Bose D, Baars T, Mohlenkamp S, Konorza T, Schoner S et al. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Circ Res 2011;108:344-352.
24. Podgoreanu MV, White WD, Morris RW, Mathew JP, Stafford-Smith M, Welsby IJ et al. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. Circulation 2006;114:I275-I281. (Pubitemid 44297163)
25. Collard CD, Shernan SK, Fox AA, Bernig T, Chanock SJ, Vaughn WK et al. The MBL2 'LYQA secretor' haplotype is an independent predictor of postoperative myocardial infarction in whites undergoing coronary artery bypass graft surgery. Circulation 2007; 116:I106-I112. (Pubitemid 47480777)
26. Liu KY, Muehlschlegel JD, Perry TE, Fox AA, Collard CD, Body SC et al. Common genetic variants on chromosome 9p21 predict perioperative myocardial injury after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2010;139:483-488.
27. Muehlschlegel JD, Liu KY, Perry TE, Fox AA, Collard CD, Shernan SK et al. Chromosome 9p21 variant predicts mortality after coronary artery bypass graft surgery. Circulation 2010;122:S60-S65.
28. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M. STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res 2012;110:111-115.
29. Raja SG, Dreyfus GD. Modulation of systemic inflammatory response after cardiac surgery. Asian Cardiovasc Thorac Ann 2005;13:382-395. (Pubitemid 41824742)
30. Suleiman MS, Zacharowski K, Angelini GD. Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics. Br J Pharmacol 2008;153:21-33.
31. Domanski MJ, Mahaffey K, Hasselblad V, Brener SJ, Smith PK, Hillis G et al. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA 2011;305:585-591.
32. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-2653. (Pubitemid 350182388)
33. Costa MA, Carere RG, Lichtenstein SV, Foley DP, de Valk V, Lindenboom W et al. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation 2001;104:2689-2693. (Pubitemid 33108135)
34. Alyanakian MA, Dehoux M, Chatel D, Seguret C, Desmonts JM, Durand G et al. Cardiac troponin I in diagnosis of perioperative myocardial infarction after cardiac surgery. J Cardiothorac Vasc Anesth 1998;12:288-294. (Pubitemid 28280362)
35. Fellahi JL, Leger P, Philippe E, Arthaud M, Riou B, Gandjbakhch I et al. Pericardial cardiac troponin I release after coronary artery bypass grafting. Anesth Analg 1999; 89:829-834. (Pubitemid 29458452)
36. Carrier M, Pellerin M, Perrault LP, Solymoss BC, Pelletier LC. Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. Ann Thorac Surg 2000;69:435-440. (Pubitemid 30127872)
37. Weber M, Bazzino O, Navarro Estrada JL, de MR, Salzberg S, Fuselli JJ et al. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J 2011;162:81-88.
38. Lurati Buse GA, Koller MT, Grapow M, Bolliger D, Seeberger M, Filipovic M. The prognostic value of troponin release after adult cardiac surgery-a meta-analysis. Eur J Cardiothorac Surg 2010;37:399-406.
39. Pegg TJ, Maunsell Z, Karamitsos TD, Taylor RP, James T, Francis JM et al. Utility of cardiac biomarkers for the diagnosis of type V myocardial infarction after coronary artery bypass grafting: insights from serial cardiac MRI. Heart 2011;97:810-816.
40. Selvanayagam JB, Petersen SE, Francis JM, Robson MD, Kardos A, Neubauer S et al. Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: a randomized trial using cardiovascular magnetic resonance imaging and biochemical markers. Circulation 2004;109:345-350. (Pubitemid 38133902)
41. Steuer J, Bjerner T, Duvernoy O, Jideus L, Johansson L, Ahlstrom H et al. Visualisation and quantification of peri-operative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging. Eur Heart J 2004;25:1293-1299. (Pubitemid 38998505)
42. Selvanayagam JB, Pigott D, Balacumaraswami L, Petersen SE, Neubauer S, Taggart DP. Relationship of irreversible myocardial injury to troponin I and creatine kinase-MB elevation after coronary artery bypass surgery: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005;45:629-631. (Pubitemid 40222261)
43. Lim CC, Cuculi F, van Gaal WJ, Testa L, Arnold JR, Karamitsos T et al. Early diagnosis of perioperative myocardial infarction after coronary bypass grafting: a study using biomarkers and cardiac magnetic resonance imaging. Ann Thorac Surg 2011;92: 2046-2053.
44. Pegg TJ, Selvanayagam JB, Francis JM, Karamitsos TD, Maunsell Z, Yu LM et al. A randomized trial of on-pump beating heart and conventional cardioplegic arrest in coronary artery bypass surgery patients with impaired left ventricular function using cardiac magnetic resonance imaging and biochemical markers. Circulation 2008;118:2130-2138.
45. Rahimi K, Banning AP, Cheng AS, Pegg TJ, Karamitsos TD, Channon KM et al. Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study. Heart 2009;95:1937-1943.
46. Nassenstein K, Breuckmann F, Bucher C, Kaiser G, Konorza T, Schafer L et al. How much myocardial damage is necessary to enable detection of focal late gadolinium enhancement at cardiac MR imaging? Radiology 2008;249:829-835.
47. Hausenloy DJ, Yellon DM. The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 2011;8:619-629.
48. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136. (Pubitemid 17174962)
49. Schmidt MR, Smerup M, Konstantinov IE, Shimizu M, Li J, Cheung M et al. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. Am J Physiol Heart Circ Physiol 2007;292:H1883-H1890. (Pubitemid 46572412)
50. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003;83:1113-1151. (Pubitemid 37222269)
51. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-277. (Pubitemid 23224422)
52. Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997;77:314-318. (Pubitemid 27208169)
53. Walsh SR, Tang TY, Kullar P, Jenkins DP, Dutka DP, Gaunt ME. Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur J Cardiothorac Surg 2008;34:985-994.
54. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993;87:893-899. (Pubitemid 23070821)
55. Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002;106:2881-2883. (Pubitemid 35424735)
56. Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res 2008;79:377-386.
57. Heusch G, Schulz R. Remote preconditioning. J Mol Cell Cardiol 2002;34:1279-1281. (Pubitemid 35244401)
58. Lim SY, Yellon DM, Hausenloy DJ. The neural and humoral pathways in remote limb ischemic preconditioning. Basic Res Cardiol 2010;105:651-655.
59. Breivik L, Helgeland E, Aarnes EK, Mrdalj J, Jonassen AK. Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion. Basic Res Cardiol 2011; 106:135-145.
60. Gunaydin B, Cakici I, Soncul H, Kalaycioglu S, Cevik C, Sancak B et al. Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery? Pharmacol Res 2000;41:493-496.
61. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006;47:2277-2282. (Pubitemid 43795071)
62. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007; 370:575-579. (Pubitemid 47247853)
63. Thielmann M, Kottenberg E, Boengler K, Raffelsieper C, Neuhaeuser M, Peters J et al. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Res Cardiol 2010; 105:657-664.
64. Rahman IA, Mascaro JG, Steeds RP, Frenneaux MP, Nightingale P, Gosling P et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment? Circulation 2010;122:S53-S59.
65. Karuppasamy P, Chaubey S, Dew T, Musto R, Sherwood R, Desai J et al. Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation? Basic Res Cardiol 2011;106:511-519.
66. Peters J. Remote ischaemic preconditioning of the heart: remote questions, remote importance, or remote preconditions? Basic Res Cardiol 2011;106:507-509.
67. Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol-a clinical trial. Acta Anaesthesiol Scand 2012;56: 30-38.
68. Huang Z, Zhong X, Irwin MG, Ji S, Wong GT, Liu Y et al. Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients. Clin Sci (Lond) 2011;121:57-69.
69. Ghosh S, Galinanes M. Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass. J Thorac Cardiovasc Surg 2003;126:133-142. (Pubitemid 36909950)
70. Hausenloy DJ, Candilio L, Laing C, Kunst G, Pepper J, Kolvekar S et al. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multicentre randomized double-blinded controlled clinical trial. Clin Res Cardiol 2011 [Epub ahead of print].
71. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ et al. Postconditioning and protection from reperfusion injury: where do we stanDi Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2010;87:406-423.
72. Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res 2006;70:200-211.
73. Luo W, Li B, Lin G, Huang R. Postconditioning in cardiac surgery for tetralogy of Fallot. J Thorac Cardiovasc Surg 2007;133:1373-1374. (Pubitemid 46635534)
74. Li B, Chen R, Huang R, Luo W. Clinical benefit of cardiac ischemic postconditioning in corrections of tetralogy of Fallot. Interact Cardiovasc Thorac Surg 2009;8:17-21.
75. Luo W, Li B, Chen R, Huang R, Lin G. Effect of ischemic postconditioning in adult valve replacement. Eur J Cardiothorac Surg 2008;33:203-208.
76. Kato R, Foex P. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Can J Anaesth 2002;49:777-791. (Pubitemid 35469040)
77. Symons JA, Myles PS. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 2006;97:127-136. (Pubitemid 44295694)
78. Yu CH, Beattie WS. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anaesth 2006;53:906-918. (Pubitemid 44696515)
79. Freedman BM, Hamm DP, Everson CT, Wechsler AS, Christian CM. Enflurane enhances postischemic functional recovery in the isolated rat heart. Anesthesiology 1985;62:29-33.
80. Feng J, Lucchinetti E, Ahuja P, Pasch T, Perriard JC, Zaugg M. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta. Anesthesiology 2005;103:987-995. (Pubitemid 41552054)
81. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999;100:II340-II344. (Pubitemid 29523557)
82. Landoni G, Biondi-Zoccai GG, Zangrillo A, Bignami E, D'Avolio S, Marchetti C et al. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007;21:502-511. (Pubitemid 47135634)
83. Avkiran M, Marber MS. Na(+)/H(+) exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Coll Cardiol 2002;39:747-753. (Pubitemid 34185318)
84. Boyce SW, Bartels C, Bolli R, Chaitman B, Chen JC, Chi E et al. Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study. J Thorac Cardiovasc Surg 2003;126:420-427. (Pubitemid 37048507)
85. Mentzer RM Jr, Bartels C, Bolli R, Boyce S, Buckberg GD, Chaitman B et al. Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. Ann Thorac Surg 2008;85:1261-1270. (Pubitemid 351381652)
86. Lee HT, LaFaro RJ, Reed GE. Pretreatment of human myocardium with adenosine during open heart surgery. J Card Surg 1995;10:665-676.
87. Mentzer RM Jr, Rahko PS, Molina-Viamonte V, Canver CC, Chopra PS, Love RB et al. Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery. Am J Cardiol 1997;79:38-43. (Pubitemid 27305167)
88. Zarro DL, Palanzo DA, Sadr FS. Myocardial preconditioning using adenosine: review and clinical experience. Perfusion 1998;13:145-150.
89. Belhomme D, Peynet J, Florens E, Tibourtine O, Kitakaze M, Menasche P. Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery? Ann Thorac Surg 2000;70:590-594.
90. Rinne T, Laurikka J, Penttila I, Kaukinen S. Adenosine with cold blood cardioplegia during coronary revascularization. J Cardiothorac Vasc Anesth 2000;14:18-20. (Pubitemid 30114929)
91. Menasche P, Jamieson WR, Flameng W, Davies MK. Acadesine: a new drug that may improve myocardial protection in coronary artery bypass grafting. Results of the first international multicenter study. Multinational Acadesine Study Group. J Thorac Cardiovasc Surg 1995;110:1096-1106.
92. Effects of acadesine on the incidence of myocardial infarction and adverse cardiac outcomes after coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Anesthesiology 1995;83:658-673.
93. Mangano DT, Miao Y, Tudor IC, Dietzel C. Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine. J Am Coll Cardiol 2006;48:206-214. (Pubitemid 43929241)
94. Wei M, Wang X, Kuukasjarvi P, Laurikka J, Rinne T, Honkonen EL et al. Bradykinin preconditioning in coronary artery bypass grafting. Ann Thorac Surg 2004;78: 492-497. (Pubitemid 38980760)
95. Wang X, Wei M, Kuukasjarvi P, Laurikka J, Rinne T, Moilanen E et al. The antiinflammatory effect of bradykinin preconditioning in coronary artery bypass grafting (bradykinin and preconditioning). Scand Cardiovasc J 2008;43:1-8.
96. Wang X, Wei M, Laurikka J, Kuukasjarvi P, Rinne T, Honkonen EL et al. The antiinflammatory effect of diazoxide in coronary artery bypass grafting. Shock 2004;22: 23-28. (Pubitemid 40228205)
97. Wang X, Wei M, Kuukasjarvi P, Laurikka J, Jarvinen O, Rinne T et al. Novel pharmacological preconditioning with diazoxide attenuates myocardial stunning in coronary artery bypass grafting. Eur J Cardiothorac Surg 2003;24:967-973. (Pubitemid 37476374)
98. Oosterga M, Voors AA, Pinto YM, Buikema H, Grandjean JG, Kingma JH et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. Am J Cardiol 2001;87:542-546. (Pubitemid 32178447)
99. Rouleau JL, Warnica WJ, Baillot R, Block PJ, Chocron S, Johnstone D et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation 2008;117:24-31. (Pubitemid 350291178)
100. Vakeva AP, Agah A, Rollins SA, Matis LA, Li L, Stahl GL. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 1998;97:2259-2267. (Pubitemid 28265388)
101. Smith PK, Shernan SK, Chen JC, Carrier M, Verrier ED, Adams PX et al. Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials. J Thorac Cardiovasc Surg 2011;142:89-98.
102. Ludman A, Venugopal V, Yellon DM, Hausenloy DJ. Statins and cardioprotection-more than just lipid lowering? Pharmacol Ther 2009;122:30-43.
103. Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004;110:II45-II49. (Pubitemid 39263697)
104. Collard CD, Body SC, Shernan SK, Wang S, Mangano DT. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2006;132:392-400. (Pubitemid 44092868)
105. Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, Dorge H et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J 2008; 29:1548-1559. (Pubitemid 351881985)
106. Mensah K, Mocanu MM, Yellon DM. Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? J Am Coll Cardiol 2005;45:1287-1291. (Pubitemid 40523151)
107. Herrmann J, Lerman A, Baumgart D, Volbracht L, Schulz R, von BC et al. Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation 2002;106:2180-2183. (Pubitemid 35222209)
108. Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. J Am Coll Cardiol 2009;54:558-565.
109. Ludman AJ, Hausenloy DJ, Babu G, Hasleton J, Venugopal V, Boston-Griffiths E et al. Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial. Basic Res Cardiol 2011;106: 1387-1395.
110. Riksen NP, Hausenloy DJ, Yellon DM. Erythropoietin: ready for prime-time cardioprotection. Trends Pharmacol Sci 2008;29:258-267.
111. Voors AA, Belonje AM, Zijlstra F, Hillege HL, Anker SD, Slart RH et al. A single dose of erythropoietin in ST-elevation myocardial infarction. Eur Heart J 2010;31: 2593-2600.
112. Ludman AJ, Yellon DM, Hasleton J, Ariti C, Babu GG, Boston-Griffiths E et al. Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial. Heart 2011;97:1560-1565.
113. Mocini D, Muso P, Guendouz E, De Marco L, Mele L, Cini R et al. Endogenous erythropoietin and a single bolus of 40,000 IU of epoetin alpha do not protect the heart from ischaemia-reperfusion injury during extracorporeal circulation for cardiac surgery. Perfusion 2008;23:187-192.
114. Bolli R, Becker L, Gross G, Mentzer R Jr, Balshaw D, Lathrop DA. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 2004; 95:125-134. (Pubitemid 38988678)
115. Kloner RA, Rezkalla SH. Cardiac protection during acute myocardial infarction: where do we stand in 2004? J Am Coll Cardiol 2004;44:276-286. (Pubitemid 38950583)
116. Ludman AJ, Yellon DM, Hausenloy DJ. Cardiac preconditioning for ischaemia: lost in translation. Dis Model Mech 2010;3:35-38.
117. Hausenloy DJ, Baxter G, Bell R, Botker HE, Davidson SM, Downey J et al. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol 2010;105:677-686.
118. Schwartz LL, Kloner RA, Arai AE, Baines CP, Bolli R, Braunwald E et al. New horizons in cardioprotection: recommendations from the 2010 national heart, lung, and blood institute workshop. Circulation 2011;124:1172-1179.
119. Boengler K, Schulz R, Heusch G. Loss of cardioprotection with ageing. Cardiovasc Res 2009;83:247-261.
120. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007;59:418-458.
121. Javadov SA, Lim KH, Kerr PM, Suleiman MS, Angelini GD, Halestrap AP. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 2000;45:360-369. (Pubitemid 30069501)
122. Lim KH, Halestrap AP, Angelini GD, Suleiman MS. Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass. Exp Biol Med (Maywood) 2005;230:413-420. (Pubitemid 40827706)
123. Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol 2002;40:1961-1967. (Pubitemid 35428831)
124. Gavard JA, Chaitman BR, Sakai S, Stocke K, Danchin N, Erhardt L et al. Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial. J Thorac Cardiovasc Surg 2003;126:807-813. (Pubitemid 37151967)
125. Kathiresan S, Servoss SJ, Newell JB, Trani D, MacGillivray TE, Lewandrowski K et al. Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality. Am J Cardiol 2004;94:879-881. (Pubitemid 39349551)
126. Lehrke S, Steen H, Sievers HH, Peters H, Opitz A, Muller-Bardorff M et al. Cardiac troponin T for prediction of short-and long-term morbidity and mortality after elective open heart surgery. Clin Chem 2004;50:1560-1567. (Pubitemid 39121224)
127. Nesher N, Alghamdi AA, Singh SK, Sever JY, Christakis GT, Goldman BS et al. Troponin after cardiac surgery: a predictor or a phenomenon? Ann Thorac Surg 2008;85:1348-1354. (Pubitemid 351381695)
128. Lasocki S, Provenchere S, Benessiano J, Vicaut E, Lecharny JB, Desmonts JM et al. Cardiac troponin I is an independent predictor of in-hospital death after adult cardiac surgery. Anesthesiology 2002;97:405-411. (Pubitemid 34847754)
129. Fellahi JL, Gue X, Richomme X, Monier E, Guillou L, Riou B. Short-and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology 2003;99:270-274. (Pubitemid 36909551)
130. Paparella D, Cappabianca G, Visicchio G, Galeone A, Marzovillo A, Gallo N et al. Cardiac troponin I release after coronary artery bypass grafting operation: effects on operative and midterm survival. Ann Thorac Surg 2005;80:1758-1764. (Pubitemid 41464297)
131. Croal BL, Hillis GS, Gibson PH, Fazal MT, El Shafei H, Gibson G et al. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 2006;114:1468-1475. (Pubitemid 44527001)
132. Venugopal V, Laing CM, Ludman A, Yellon DM, Hausenloy D. Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. Am J Kidney Dis 2010;56:1043-1049.
133. Ali N, Rizwi F, Iqbal A, Rashid A. Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass. J Coll Physicians Surg Pak 2010;20:427-431.
134. Wagner R, Piler P, Bedanova H, Adamek P, Grodecka L, Freiberger T. Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial. Interact Cardiovasc Thorac Surg 2010;11:758-762.
135. Li L, Luo W, Huang L, Zhang W, Gao Y, Jiang H et al. Remote perconditioning reduces myocardial injury in adult valve replacement: a randomized controlled trial. J Surg Res 2010;164:e21-e26.
136. Hong DM, Mint JJ, Kim JH, Sohn IS, Lim TW, Lim YJ et al. The effect of remote ischaemic preconditioning on myocardial injury in patients undergoing off-pump coronary artery bypass graft surgery. Anaesth Intensive Care 2010;38:924-929.
137. Choi YS, Shim JK, Kim JC, Kang KS, Seo YH, Ahn KR et al. Effect of remote ischemic preconditioning on renal dysfunction after complex valvular heart surgery: a randomized controlled trial. J Thorac Cardiovasc Surg 2011;142:148-154.